| Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells R Sommaggio, E Cappuzzello, A Dalla Pietà, A Tosi, P Palmerini, ... Oncoimmunology 9 (1), 1777046, 2020 | 42 | 2020 |
| Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells A Dalla Pietà, E Cappuzzello, P Palmerini, A Ventura, A Visentin, G Astori, ... Journal for ImmunoTherapy of Cancer 9 (7), 2021 | 16 | 2021 |
| A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks P Palmerini, A Dalla Pietà, R Sommaggio, A Ventura, G Astori, ... Cytotherapy 22 (9), 511-518, 2020 | 13 | 2020 |
| Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma S Viragova, L Aparicio, P Palmerini, J Zhao, LE Valencia Salazar, ... JNCI: Journal of the National Cancer Institute 115 (7), 838-852, 2023 | 9 | 2023 |
| A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis … M Severa, F Rizzo, A Sinigaglia, D Ricci, MP Etna, G Cola, D Landi, ... Clinical & Translational Immunology 12 (3), e1434, 2023 | 3 | 2023 |
| 377 Adoptive cell therapy with cytokine-induced killer cells retargeted with immunotools against HER-2 positive breast cancer R Sommaggio, E Cappuzzello, A Ventura, S Perpinello, A Dalla Pieta, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 157P Adoptive cell therapy with cytokine-induced killer cells retargeted with immunotools against HER-2-expressing breast cancer S Perpinello, E Cappuzzello, R Sommaggio, A Ventura, P Palmerini, ... Annals of Oncology 33, S192, 2022 | | 2022 |
| P06. 06 Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells R Sommaggio, E Cappuzzello, A Dalla Pietà, P Palmerini, A Tosi, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
| P09. 13 Optimization of a GMP-grade large-scale expansion protocol for cytokine-induced killer cells using gas-permeable static culture flasks A Ventura, P Palmerini, A Dalla Pietà, R Sommaggio, G Astori, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
| P09. 01 Adoptive cell therapy of hematological malignancies using cytokine-induced killer cells retargeted with monoclonal antibodies A Dalla Pietà, E Cappuzzello, P Palmerini, R Sommaggio, G Astori, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
| Optimization of a gmp-grade large-scale expansion protocol for cytokine-induced killer cells using gas-permeable static culture flasks P Palmerini, E Cappuzzello, A Dalla Pietà, R Sommaggio, G Astori, ... Cytotherapy 22 (5), S116, 2020 | | 2020 |
| Adoptive cell therapy of hematological malignancies using cytokine-induced killer cells retargeted with monoclonal antibodies E Cappuzzello, A Dalla Pietà, P Palmerini, R Sommaggio, G Astori, ... Cytotherapy 22 (5), S116-S117, 2020 | | 2020 |
| Antigen-specific targeting of triple negative breast cancer using Cytokine-Induced Killer cells redirected with monoclonal antibodies R Sommaggio, E Cappuzzello, A Dalla Pieta, P Palmerini, A Tosi, ... HUMAN GENE THERAPY 30 (11), A71-A71, 2019 | | 2019 |
